Peter A. Campochiaro
Advanced in Cone Dystrophy

Dr. Peter A. Campochiaro

Ophthalmology
Johns Hopkins Medicine
The Johns Hopkins Hospital
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, 
Baltimore, MD 

Advanced in Cone Dystrophy
Johns Hopkins Medicine
The Johns Hopkins Hospital
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991.

Dr. Campochiaro is rated as an Advanced provider by MediFind in the treatment of Cone Dystrophy. His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

His clinical research consists of co-authoring 156 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
UVA Health University Hospital, Ophthalmology, 1982
Specialties
Ophthalmology
Licenses
Ophthalmology in MD
Board Certifications
American Board Of Ophthalmology
Hospital Affiliations
The Johns Hopkins Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

The Johns Hopkins Hospital
1800 Orleans Street, Maumenee Lobby, Maumenee Lobby, Baltimore, MD 21287
Call: 410-955-5080

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
Connective Tissue Growth Factor in Patients With Neovascular Age Related Macular Degeneration
Enrollment Status: Terminated
Publish Date: September 26, 2022
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
Enrollment Status: Terminated
Publish Date: September 26, 2022
Intervention Type: Other
A Phase 1b, Randomized, Uncontrolled, Single-masked, Safety, Tolerability, and Pharmacokinetic Study of Multiple Doses of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Human Subjects Undergoing Elective Pars Plana Vitrectomy (PPV)
A Phase 1b, Randomized, Uncontrolled, Single-masked, Safety, Tolerability, and Pharmacokinetic Study of Multiple Doses of Three Different Concentrations (0.1%, 1.0%, 5.0%) of SAR 1118 Ophthalmic Solution in Human Subjects Undergoing Elective Pars Plana Vitrectomy (PPV)
Enrollment Status: Terminated
Publish Date: May 10, 2017
Intervention Type: Drug
Study Phase: Phase 1
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Enrollment Status: Completed
Publish Date: April 28, 2017
Intervention Type: Drug
Study Phase: Phase 2
View 3 Less Clinical Trials

156 Total Publications

Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa.
Protocol for NAC Attack, a phase-3, multicenter randomized, parallel, double masked, placebo controlled trial evaluating the efficacy and safety of oral N-acetylcysteine (NAC) in patients with retinitis pigmentosa.
Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025
View All 156 Publications
Similar Doctors
Distinguished in Cone Dystrophy
Dr. Joseph B. Harlan
Ophthalmology
Distinguished in Cone Dystrophy
Dr. Joseph B. Harlan
Ophthalmology

Katzen Medical Associates PC

1209 York Rd, 
Lutherville, MD 
 (8.3 miles away)
410-821-9490
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Harlan is an Ophthalmologist in Lutherville, Maryland. Dr. Harlan is rated as a Distinguished provider by MediFind in the treatment of Cone Dystrophy. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, Retinal Artery Occlusion, and Age-Related Macular Degeneration (ARMD). Dr. Harlan is currently accepting new patients.

Mandeep Singh
Distinguished in Cone Dystrophy
Dr. Mandeep Singh
Ophthalmology
Distinguished in Cone Dystrophy
Dr. Mandeep Singh
Ophthalmology

The Johns Hopkins Hospital

Baltimore, MD 
 (0.1 miles away)
410-955-5080
Languages Spoken:
English, Malaysian, Punjabi
See accepted insurances

Mandeep S. Singh, M.D., Ph.D., is associate professor of ophthalmology and genetic medicine in the Retina Division of the Wilmer Eye Institute and the recipient of the 2023 Andreas C. Dracopoulos Professorship in Ophthalmology. Dr. Singh is a retinal specialist. He is Co-Director of the Genetic Eye Disease (GEDi) Center, and is a principal investigator at the Center for Stem Cells and Ocular Regenerative Medicine (STORM). Dr. Singh completed his medical degree at the National University of Singapore. In 2009, he was elected to the Fellow of the Royal College of Surgeons of Edinburgh. He earned a PhD in ophthalmology from the University of Oxford, United Kingdom, in 2014. He completed fellowships in vitreoretinal diseases and surgery at the Oxford Eye Hospital and Moorfields Eye Hospital, both in the United Kingdom. His clinical expertise includes surgical, medical and genetic conditions of the retina and macula. Dr. Singh is specialty-trained in vitrectomy surgery for retinal detachment, macular holes, macular pucker, epiretinal membrane, proliferative vitreoretinopathy, complex retinal detachments including reoperations, vitreous hemorrhage removal, and other retinal surgeries. He also specializes in age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vein occlusion, and choroidal neovascularization. Dr. Singh sees patients and families with genetic retinal diseases such as retinitis pigmentosa, Usher syndrome, Stargardt disease and macular dystrophies. His research focus is retinal stem cell transplantation. Dr. Singh’s work has been recognized through the Eye Institute–Allergan Research Prize, the Merton College University of Oxford Graduate Prize Scholarship, the Oxford Ophthalmological Congress Founder’s Cup and Medal, the Ruskell Medal, the Johns Hopkins Clinician Scientist Award, and the Bert M. Glaser, MD Award for Innovative Research in Retina. He is a member of the American Academy of Ophthalmology and the Association for Research in Vision and Ophthalmology. He is also a member of the Club Jules Gonin and the Macula Society. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Singh_CV.pdf. Dr. Singh is rated as an Elite provider by MediFind in the treatment of Cone Dystrophy. His top areas of expertise are Retinitis Pigmentosa, Stargardt Macular Degeneration, Late-Onset Retinal Degeneration, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

Distinguished in Cone Dystrophy
Dr. Janet S. Sunness
Ophthalmology
Distinguished in Cone Dystrophy
Dr. Janet S. Sunness
Ophthalmology

Greater Baltimore Medical Center Inc

6569 N Charles St, 
Baltimore, MD 
 (6.6 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Janet Sunness is an Ophthalmologist in Baltimore, Maryland. Dr. Sunness is rated as an Elite provider by MediFind in the treatment of Cone Dystrophy. Her top areas of expertise are Stargardt Macular Degeneration, Geographic Atrophy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD). Dr. Sunness is currently accepting new patients.

VIEW MORE CONE DYSTROPHY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Campochiaro's expertise for a condition
ConditionClose
  • Elite
  • Age-Related Macular Degeneration (ARMD)
    Dr. Campochiaro is
    Elite
    . Learn about Age-Related Macular Degeneration (ARMD).
    See more Age-Related Macular Degeneration (ARMD) experts
  • Diabetic Macular Edema (DME)
    Dr. Campochiaro is
    Elite
    . Learn about Diabetic Macular Edema (DME).
    See more Diabetic Macular Edema (DME) experts
  • Late-Onset Retinal Degeneration
    Dr. Campochiaro is
    Elite
    . Learn about Late-Onset Retinal Degeneration.
    See more Late-Onset Retinal Degeneration experts
  • Retinal Vein Occlusion
    Dr. Campochiaro is
    Elite
    . Learn about Retinal Vein Occlusion.
    See more Retinal Vein Occlusion experts
  • Retinitis Pigmentosa
    Dr. Campochiaro is
    Elite
    . Learn about Retinitis Pigmentosa.
    See more Retinitis Pigmentosa experts
  • Retinopathy Pigmentary Mental Retardation
    Dr. Campochiaro is
    Elite
    . Learn about Retinopathy Pigmentary Mental Retardation.
    See more Retinopathy Pigmentary Mental Retardation experts
  • Distinguished
  • Diabetic Retinopathy
    Dr. Campochiaro is
    Distinguished
    . Learn about Diabetic Retinopathy.
    See more Diabetic Retinopathy experts
  • Retinal Detachment
    Dr. Campochiaro is
    Distinguished
    . Learn about Retinal Detachment.
    See more Retinal Detachment experts
  • Advanced
  • Cone Dystrophy
    Dr. Campochiaro is
    Advanced
    . Learn about Cone Dystrophy.
    See more Cone Dystrophy experts
  • Cone Rod Dystrophy Amelogenesis Imperfecta
    Dr. Campochiaro is
    Advanced
    . Learn about Cone Rod Dystrophy Amelogenesis Imperfecta.
    See more Cone Rod Dystrophy Amelogenesis Imperfecta experts
  • Cone-Rod Dystrophy
    Dr. Campochiaro is
    Advanced
    . Learn about Cone-Rod Dystrophy.
    See more Cone-Rod Dystrophy experts
  • Doyne Honeycomb Retinal Dystrophy
    Dr. Campochiaro is
    Advanced
    . Learn about Doyne Honeycomb Retinal Dystrophy.
    See more Doyne Honeycomb Retinal Dystrophy experts
  • Endophthalmitis
    Dr. Campochiaro is
    Advanced
    . Learn about Endophthalmitis.
    See more Endophthalmitis experts
  • Stargardt Macular Degeneration
    Dr. Campochiaro is
    Advanced
    . Learn about Stargardt Macular Degeneration.
    See more Stargardt Macular Degeneration experts
View All 10 Advanced Conditions
  • Experienced
  • Adult-Onset Vitelliform Macular Dystrophy (AVMD)
    Dr. Campochiaro is
    Experienced
    . Learn about Adult-Onset Vitelliform Macular Dystrophy (AVMD).
    See more Adult-Onset Vitelliform Macular Dystrophy (AVMD) experts
  • Cataract
    Dr. Campochiaro is
    Experienced
    . Learn about Cataract.
    See more Cataract experts
  • Cataract Removal
    Dr. Campochiaro is
    Experienced
    . Learn about Cataract Removal.
    See more Cataract Removal experts
  • Choroid Plexus Carcinoma
    Dr. Campochiaro is
    Experienced
    . Learn about Choroid Plexus Carcinoma.
    See more Choroid Plexus Carcinoma experts
  • Geographic Atrophy
    Dr. Campochiaro is
    Experienced
    . Learn about Geographic Atrophy.
    See more Geographic Atrophy experts
  • Glaucoma
    Dr. Campochiaro is
    Experienced
    . Learn about Glaucoma.
    See more Glaucoma experts
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.